Fig. 5From: A physiologically based pharmacokinetic model for [68Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patientsPredictions of tumor sink effect for each tumor compartment (points and lines) (where primary tumor and liver metastases predictions are overlapping) with ranges in predictions (shaded areas) based on inter-individual variability of tumor blood flow and tumor blood volumeBack to article page